News

Mydecine Provides Company Update; Welcomes New Board Member

DENVER, June 09, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the…

2 years ago

BioCryst Selects Pint Pharma as Commercial Partner for ORLADEYO® (berotralstat) in Latin America

RESEARCH TRIANGLE PARK, N.C., June 09, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the company has entered…

2 years ago

Tonix Pharmaceuticals Announces Data Presentations Involving TNX-1500 (Fc-modified anti-CD40L mAb) for the Prevention of Rejection in Kidney and Heart Allograft Transplantation in Animal Models at the 2022 American Transplant Congress

Research Directed by Faculty of the Center for Transplantation Sciences, Massachusetts General HospitalCHATHAM, N.J., June 09, 2022 (GLOBE NEWSWIRE) --…

2 years ago

BioAdaptives, Inc. Reveals Corporate Strategy for a Strengthened Market Presence, Through Empowerment of Seniors, as Nutraceutical Market Surpasses $454 Billion USD

Management Pursues Growth By Bringing Advanced Wellness Through Advantageous Senior Pricing LAS VEGAS, NV, June 09, 2022 (GLOBE NEWSWIRE) --…

2 years ago

Mesoblast Key Opinion Leader Event Series for Investors & Analysts

Chronic Low Back Pain due to Degenerative Disc DiseaseNEW YORK, June 09, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB),…

2 years ago

Tiziana Life Sciences Announces Purchase of Common Shares by Executive Chairman

NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd.(Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company…

2 years ago

Exavir Therapeutics announces publication of preclinical data for ultra-long-acting dolutegravir prodrug XVIR-120

Ultra-long-acting plasma pharmacokinetics and biodistribution to tissues of interest demonstrated in three species Injections were well tolerated with no adverse…

2 years ago

Satsuma Pharmaceuticals Announces Five Abstracts Accepted for Presentation at The American Headache Society’s 64th Annual Scientific Meeting

Oral Presentation: Initial Data from ASCEND Study Highlights STS101’s Long-Term Safety and TolerabilitySOUTH SAN FRANCISCO, Calif., June 09, 2022 (GLOBE…

2 years ago

Nova Mentis and University of Central Florida to Develop Saliva Serotonin Assay

Vancouver, British Columbia--(Newsfile Corp. - June 9, 2022) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF)…

2 years ago

Medical Device Innovation Consortium (MDIC) Announces Andrew Fish, JD Appointed as President and Chief Executive Officer (CEO)

ARLINGTON, Va.--(BUSINESS WIRE)--The Medical Device Innovation Consortium (MDIC) today announced that Andrew Fish, JD has been appointed as President and…

2 years ago